Mylan NV (MYL) Partnership Means The Race Is Back On For Mabion SA (MAB) And Its Billion Dollar Rituximab Biosimilar

Polish biotech company Mabion SA (WSE:MAB) just announced the signing of a supply and commercialization agreement with Mylan NV (NASDAQ:MYL), by way of its subsidiary Mylan Ireland...

Keep Reading →